Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongcheng Dayang Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a wholly-owned subsidiary of Dongcheng Pharmaceutical Group. Based in Yantai, the company specializes in the production of chemical drugs and traditional Chinese medicine, with a strong focus on cardiovascular and anti-thrombotic therapies. Its product portfolio includes key treatments such as Enoxaparin Sodium and Heparin Sodium, alongside a range of oral solid dosages for various therapeutic areas. The company operates state-of-the-art GMP-certified facilities, supporting the parent group's integrated supply chain from raw materials to finished formulations. Dongcheng Dayang plays a critical role in the group's domestic market presence and manufacturing excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 烟台东诚大洋制药.